COMMUNIQUÉS West-GlobeNewswire

Zynerba Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference

14/03/2018 - 14:00

DEVON, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]

BLVD Centers Launches Weedaide™ Website in Advance of Product Launch

14/03/2018 - 14:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“ BLVD ” or the “ Company ”) (TSXV:CXV), a [...]

Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing

14/03/2018 - 14:00

LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical , (OTC:CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing. Bringing more than 35 years [...]

PRA Health Sciences Receives CRO Leadership Award

14/03/2018 - 14:00

RALEIGH, N.C., March 14, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce it has won a 2018 CRO Phase IV Leadership Award (Overall, Big Pharma). For the 2018 CRO Leadership [...]

Immunicum AB: The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board

14/03/2018 - 13:44

Press Release 14 March 2018 The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board The Nomination Committee of Immunicum (publ; IMMU.ST) has informed the Company that they [...]

Kalytera Announces Grant of Stock Options to Chief Scientific Officer and Chief Medical Officer

14/03/2018 - 13:30

SAN FRANCISCO and TEL AVIV, Israel, March 14, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that it has granted stock options on [...]

Hemispherx Biopharma and UNMC Partner to Take on Pancreatic Cancer

14/03/2018 - 13:30

ORLANDO, Fla., March 14, 2018 (GLOBE NEWSWIRE) -- The University of Nebraska Medical Center and Hemispherx Biopharma, Inc. (NYSE American:HEB) are joining forces to take on pancreatic cancer, one of the most deadly [...]

American Cannabis Company, Inc. Secures New Online Distribution Channels with Walmart, The Home Depot and Amazon for SoHum Living Soils and Dr. Marijane Root Probiotic

14/03/2018 - 13:30

DENVER, CO, March 14, 2018 (GLOBE NEWSWIRE) -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis [...]

GTX Corp Prepares to Launch New Suite of GPS Tracking Solutions Expanding Beyond the Alzheimer's Market

14/03/2018 - 13:30

LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive GPS technology business, is launching [...]

Bespoke Extracts Announces Title Sponsorship of Hairy Kiwi Racing Team and Professional Sportbike Racer Robertino Pietri

14/03/2018 - 13:30

New Partnership Launches this Weekend at the 77 th Annual Running of DAYTONA 200, America’s Most Historic Motorcycle Road Race SUNNY ISLES, Fla., March 14, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC Pink:BSPK [...]

Sharps Compliance to Attend Gabelli & Company’s 4th Annual Waste & Environmental Services Symposium

14/03/2018 - 13:20

HOUSTON, March 14, 2018 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED ) announced today that David P. Tusa, President and Chief Executive Officer, will be presenting at Gabelli & Company’s 4 th Annual [...]

Achaogen to Present at Needham & Company’s 17th Annual Healthcare Conference

14/03/2018 - 13:01

-- Company presentation scheduled for March 27, 2018 -- SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative [...]

CASMED Reports 2017 Fourth-Quarter and Full-Year Financial Results

14/03/2018 - 13:00

U.S. FORE-SIGHT sales increased 18% in Q4 on record 80 placements Conference Call Begins Today at 10:00 a.m. Eastern Time BRANFORD, Conn., March 14, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) ( [...]

MannKind Corporation to Present at Oppenheimer 28th Annual Healthcare Conference

14/03/2018 - 13:00

WESTLAKE VILLAGE, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Melinta Therapeutics to Present at Needham & Company’s 17th Annual Healthcare Conference

14/03/2018 - 13:00

NEW HAVEN, Conn., March 14, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

RavenQuest Announces Dr. Simerjeet Kaur Will Lead Scientific Research & Development

14/03/2018 - 13:00

VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has appointed Dr. Simerjeet Kaur, PhD, to lead Scientific [...]

Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results

14/03/2018 - 13:00

WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Spring Bank Announces Presentation of Combined Inarigivir 25 mg and 50 mg 12 and 24 Week ACHIEVE Results Demonstrating Enhanced Anti-Viral Efficacy in HBeAg-Negative Patients

14/03/2018 - 13:00

Data from the combined first two low dose inarigivir cohorts at weeks 12 and 24 with sequential Viread dosing demonstrate significant reductions in HBV DNA, HBV RNA and HBsAg Data to be presented at the APASL 2018 [...]

Clifford Sarkin Appointed to Millennium BlockChain Board of Advisors

14/03/2018 - 13:00

SANTA MONICA, CA, March 14, 2018 (GLOBE NEWSWIRE) -- Millennium BlockChain Inc. (OTC: MBLC ; the “Company”) is pleased to announce that Clifford Sarkin has joined the Company’s board of advisors. Sarkin is a strategic [...]